Jump Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
NAMA
Jump Financial's PACB Position: Q2 2026 in Review
Jump Financial sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 25,492 shares — an estimated $33.6K sold.
Jump Financial first reported a position in PACB in Q1 2021 and held it in 13 quarters. The position peaked at $3.3M in Q3 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Jump Financial reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
- Jump Financial sold 25,492 Pacific Biosciences shares in Q2 2026, an estimated $33.6K.
- Jump Financial first reported a position in Pacific Biosciences in Q1 2021 and held it in 13 quarters.
- Jump Financial's Pacific Biosciences position peaked at $3.3M in Q3 2023.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.